Innovation Sprint Srl, a Belgian SME founded in 2016, specializes in providing advanced technology solutions for the eHealth and Life Sciences sectors, particularly focusing on Big Data analytics and Artificial Intelligence applied to Real World Data. With a team boasting over 20 years of experience in the healthcare domain and an impressive research background of 500+ peer-reviewed papers and 35,000+ research citations, the company is at the forefront of innovation.
The product of Innovation Sprint is Healthentia, is an eClinical platform designed to assist pharmaceutical companies in achieving cost savings and gaining valuable insights during clinical studies. Healthentia stands out by capturing clinical outcomes from a variety of sources, including mobile devices, medical devices, and IoT devices, through a patient-centric app. The platform offers AI-driven smart services such as behavioral phenotyping, in-silico trials, and virtual coaching.
Innovation Sprint adopts a multidisciplinary approach, bringing together experts from clinical, ICT, signal processing, and machine learning to enhance clinical and healthcare processes and develop personalized healthcare solutions. Healthentia, as a novel solution, addresses key challenges in clinical research and MedTech, facilitating decentralized clinical trials and providing advanced remote patient monitoring services and digital therapeutics.
The company’s overarching vision is to revolutionize decentralized clinical trials, contributing significantly to the ongoing digital transformation of the life sciences and healthcare industries. The goal is to make clinical trials and digital healthcare services universally accessible, promoting overall health and well-being.
